Diabetic Foot Ulcer Treatment Market (By Type: Advanced Wound Care, Biologics, Dressings; By Ulcer Type: Neuropathic Ulcers, Neuro-ischemic Ulcers, Ischemic Ulcers; By Grade; By Treatment Type; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030


The global diabetic foot ulcer treatment market size was valued at USD 8.6 billion in 2021 and is projected to reach around USD 14.8 billion by 2030, poised to grow at a compound annual growth rate (CAGR) of 6.22% from 2022 to 2030.

Diabetic Foot Ulcer Treatment Market Size 2022 To 2030

Key Takeaways:

  • The North America diabetic foot ulcer treatment market size was valued at USD 3.8 billion in 2021
  • The wound care dressing segment accounted market share of over 43% in 2021
  • In 2021, Neuro-ischemic Ulcers segment has contributed markets share of over 45%
  • North America has garnered market share of over 53% in 2021

The rapid modernization and urbanization has boosted lifestyle practices of the people which have given rise to a number of chronic diseases. Among the many others the most common chronic disease which has been observed among the people is diabetes. There are multiple complications which diabetic individual has to face as a result of the lack of old healing power of the body which leads to easy creation of sepsis and infection.

Diabetic foot ulcer is one of the major complications which is faced by a diabetic person as the wound healing power of the body is it reduced tremendously. It is the formation of a wound usually in the foot of the patient which undergoes rapid decomposition and leads to the production of infectious microorganisms in that particular area. The diabetic patients usually rely on certain common medications which they have to take on a regular basis in order to maintain their sugar levels. One of them is the injection of insulin into the body externally. These patients usually have higher and say of having a diabetic foot ulcer as a result of the minute injuries that take place during the process of injection. 

The increasing sedentary lifestyle practices have increased the number of people suffering with obesity. This becomes another causative factor for people suffering with diabetes and other chronic diseases. It also proves to be a complication which leads to diabetic foot ulcers as the heavy weight of the body is forced upon the foot leading to multiple injuries. 

The occurrence of pandemic had a considerable impact on the market of the diabetic foot ulcer treatment. Respect government rules and regulations regarding restricted movement had hampered the patient flow of diabetic foot ulcer to the hospitals and health care center. The constant clock down so I am for the movement of the patients which restricted the scope of treatment provided by the health care centers. The demand and supply chain of the medical equipments and medicines between the manufacturer and the hospitals concerning the diabetic foot ulcer treatment was disrupted which hampered the growth of the market tremendously.

The disposable income of the people infected during the pandemic was exhausted in treating covid which did not leave any scope for diabetic foot ulcer treatment. The high costs associated with the medicines which are used for treating diabetic foot ulcer were not supplied in the adequate quantities which imposed and additional pressure on the market by increasing their cost further. Moreover, diabetes became another complication during the pandemic which exhausted the supplies of the medicines required for managing diabetes. This complication further led to new established cases of diabetes. The supply and demand of insulin was also hampered during the course of the pandemic. These multiple reasons during the covid crisis hampered the diabetic foot ulcer treatment market to a great extent.

Report Scope of the Diabetic Foot Ulcer Treatment Market

Report Coverage Details
Market Size in 2022 USD 9.13 Billion
Market Size by 2030

USD 14.8 Billion

Growth Rate from 2022 to 2030 CAGR of 6.22%
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Type, Ulcer Type, Grade, Treatment Type, End User, Geography
Companies Mentioned

ConvaTec Group Plc, 3M, B. Braun Melsungen AG, Medline Industries, Inc., Coloplast Group, Smith & Nephew, Cardinal Health Inc, Organogenesis Inc., URGO, Kerecis, Mölnlycke Health Care AB., MiMedx


Growth factors

A high prevalence of diabetes among the people all over the world has increased the risk of related complications very common in the society. Among the many other complications, the most major complication of all is the development of a diabetic foot ulcer. This is the creation of a complex wound in the foot region of the lower limbs of the individual which is very difficult to heal due to its lack of capacity to heal itself. On the other hand, management of such a wound becomes very difficult pertaining to the complexities involved in cleaning of such wounds and washing them with the required solutions. High skilled workforce is required in order to bring about a successful healing process of such a complicated wound. A number of different types of advanced medicines have to be employed in order to bring about a successful healing process and to prevent further sepsis. These medicines are highly costly and are not very easily available in the market due to their rare demands as a result of their high cost. Lack of physical activity among the youngsters as a result of their busy lifestyles and sedentary working habits have increased the risk of obesity and it's related disorders. One of the major disorder caused due to obesity is diabetes which is a cause of many other complications in the human body.

Management of a diabetic foot ulcer requires properly trained individuals with knowledge of anatomy and infection management. These factors are supporting the growth of the market actively and helping the medicine manufacturers to reap good returns from the market. The hospitals providing advanced facilities to the diabetic patients are seeing a growing demand for the management of diabetes and diabetic foot ulcer. The occurrence of the pandemic has helped the market negatively as well as positively. With the strict lockdowns and restricted movement the inflow of the patients to the healthcare center was reduced which hampered the treatment of the diabetic foot patients. It had slowed down the demand and supply of the medicines required for treatment. 

On the other hand, complication of covid which was diabetes help to create a new market for the diabetic foot ulcer treatment. New cases and patients were developed over suffering with diabetes. This will prove to be a great opportunity for the growth of the diabetic foot ulcer market during the forecast period. The rapid organisation of the world has given rise to faulty food habits which in turn gives rise to numerous chronic diseases. 

Diabetes being the most common among them proves to be a great opportunity for the growth of the market. The use genetic population presiding in the developed nations proves to be a great market for the diabetic foot ulcer treatment. Since this disease is such that it cannot be managed by the patient themselves, the role of the health care centre becomes very important. Hence the use of proper quality of medical equipments and medicines comes into play, which helps the market to show a significant growth during the forecast period.

Type Insights

Advanced wound care has dominated the segment as a result of the modern techniques and medicines that are put into use by the medical fraternity in order to obtain better results and fast healing of wounds. The the advanced methods though are costly help to provide a successful treatment and healing process for the patients. It also helps the medical fraternity to have a better judgement regarding the condition of the patients. 

The dressing of the patients is a very essential part of treatment, hence it forms the next important sector of the segment. This segment is expected to show the fastest growth during the forecast period. Modern medicines are being used in performing the dressing of the patients which helps the wound to heal faster. Biologics forms the next segment under this heading which is showing a considerable growth.

Ulcer Type Insights

Neuropathic ulcers are the most common type of ulcers that the patients are seen with. Hence this segment dominated the market under this category. This type is the most difficult to manage as it produces immense pain and discomfort to the individual hence the use of medicines also increases which helps to boost the revenue return for the diabetic foot ulcer treatment market.

The ischemic type of ulcers forms the next segment which is found among the patients with a more serious type of pathological change. The tissue of the part degrades heavily and needs to be surgically removed in order to heal the wound which provides the market a great opportunity to show the efficiency and efficacy of its medicines. The combination of both these types forms the last type under this heading. 

End User Insights

Hospitals becomes the primary place where a patient first approaches under such circumstances which makes it the largest market under this segment. The management of such big and complex ulcers takes place only in a hospital setup where all the other facilities are available. A well trained medical staff is required in order to manage a diabetic foot ulcer properly and facilitate healing. This is available only in a hospital setup where other multiple services are provided with the availability of a qualified doctor too. Home care becomes the next largest market under this segment as a number of patients prefer being treated in their own comfort zone. This market caught pace during the pandemic when patients were not attended by the hospitals to avoid the risk of cross infection. People arranged for their treatment and managed under their own comfort zone which boosted the market. Ambulatory surgery units are the last type under this segment where management of such cases takes place. 

Diabetic Foot Ulcer Treatment Market Share, By Region, 2021 (%)

Regions Revenue Share in 2021 (%)
North America 53%
Asia Pacific 15%
Europe 21%
Latin America 6%
MEA 5%


Geography Insights

The North American market has dominated the segment due to the presence of the huge geriatric population in this region. Diabetes is the most common disease in this age group which often leads to diabetic foot ulcers. The sedentary lifestyle practices followed by the people have increased the number of cases of diabetic foot ulcer. Every second person in this region supports with diabetes which helps to boost the market for diabetic foot ulcer treatment.

The Asia Pacific region forms the next sector which dominates the segment as a result of the use number of questions belonging to this region. The rapid urbanization seen in this region has led to sedentary lifestyle and faulty food habits which leads to diabetes and it's complications. The European market has too made a significant contribution to the growth of the market. 

Recent developments

  • In January 2019 – a new product for wound care has been introduced to the European market by UPM. FibDex is based on advanced technologies which offer the first ulcer dressing which is created from a nanofibrillar cellulose which is wood-based and is in process to be granted regulatory approval. It also is awaited to receive a CE mark. 
  • In December 2019- Orpyx Medical Technologies introduced Orpyx Sensory Insoles which includes remote monitoring of patients in order to prevent the cases of diabetic foot ulcer. Neuropathic ulcers are also expected to be prevented by this system.

Key market players

  • ConvaTec Group Plc
  • 3M
  • B. Braun Melsungen AG
  • Medline Industries, Inc.
  • Coloplast Group
  • Smith & Nephew
  • Cardinal Health Inc
  • Organogenesis Inc.
  • URGO
  • Kerecis
  • Mölnlycke Health Care AB.
  • MiMedx

Segments covered in the report.

(Note*: We offer report based on sub segments as well. Kindly, let us know if you are interested)

By Type

  • Advanced Wound Care
  • Biologics
  • Dressings

By Ulcer Type

  • Neuropathic Ulcers
  • Neuro-ischemic Ulcers
  • Ischemic Ulcers

By Grade

  • Grade 1
  • Grade 2
  • Grade 3
  • Grade 4
  • Grade 5

By Treatment Type

  • Wound Care Dressings
  • Wound Care Devices
  • Active Therapies
  • Others

By End User

 By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions

What is the current size of diabetic foot ulcer treatment market?
The global diabetic foot ulcer treatment market size was accounted at USD 8.6 billion in 2021 and it is expected to reach around USD 14.8 billion by 2030.
The global diabetic foot ulcer treatment market is poised to grow at a CAGR of 6.22% from 2022 to 2030.
The major players operating in the diabetic foot ulcer treatment market are ConvaTec Group Plc, 3M, B. Braun Melsungen AG, Medline Industries, Inc., Coloplast Group, Smith & Nephew, Cardinal Health Inc, Organogenesis Inc., URGO, Kerecis, Mölnlycke Health Care AB., MiMedx
The rapid urbanization world wide has resulted into sedentary lifestyles and faulty food habits amongst the people. This has resulted into obesity and diabetes among the people belonging to various age groups.
North America region will lead the global diabetic foot ulcer treatment market during the forecast period 2022 to 2030.
  • Report Code:1896
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Status:Published

PROCEED TO BUY

   USD 4500
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample